TriSalus Life Sciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WEALTHCARE ADVISORY PARTNERS LLC | 01/15/2025 | 643,740 | $3.23 M | 0.00% | 2.43% |
| DUQUESNE FAMILY OFFICE LLC | 02/14/2025 | 426,921 | $2.14 M | 0.00% | 1.61% |
| MSD PARTNERS, L.P. | 02/14/2025 | 39,999 | $200,395 | 0.00% | 0.15% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 30,270 | $151,653 | 0.00% | 0.11% |
| CONNECTIVE CAPITAL MANAGEMENT, LLC | 02/18/2025 | 27,989 | $140,225 | 100.00% | 0.11% |
| VESTCOR INC | 02/10/2025 | 23,376 | $117,000 | 0.00% | 0.09% |
| CONNECTICUT WEALTH MANAGEMENT, LLC | 02/18/2025 | 22,303 | $111,738 | -32.17% | 0.08% |
| STATE STREET CORP | 02/14/2025 | 20,200 | $101,202 | 81.98% | 0.08% |
| GILDER GAGNON HOWE & CO LLC | 02/14/2025 | 14,420 | $72,244 | -0.14% | 0.05% |
| LIDO ADVISORS, LLC | 02/14/2025 | 14,024 | $70,260 | -59.96% | 0.05% |
| ANGELO GORDON & CO., L.P. | 02/14/2025 | 10,854 | $54,379 | -47.95% | 0.04% |
| EXOS ASSET MANAGEMENT LLC | 02/13/2025 | 3,604 | $18,056 | -90.66% | 0.01% |
| HOERTKORN RICHARD CHARLES | 02/12/2025 | 668 | $3,347 | 0.00% | 0.00% |
| SIGNATUREFD, LLC | 02/10/2025 | 100 | $501 | 0.00% | 0.00% |
| MAGNETAR FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TriSalus Life Sciences, Inc. institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of TriSalus Life Sciences, Inc.. The most heavily invested institutionals were:
Wealthcare Advisory Partners LLC: 643,740
Duquesne Family Office LLC: 426,921
MSD Partners, L.P.: 39,999
BlackRock Funding, Inc. /DE: 30,270
Connective Capital Management, LLC: 27,989
Vestcor Inc: 23,376
8.85% of TriSalus Life Sciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.28 M shares in the last 24 months. This purchase volume represents approximately $6.44 M in transactions.